İlyas ATAR, Casit Olgun ÇELİK, Volkan CAMKIRAN, Orçun ÇİFTÇİ, Bülent OZİN

The role of right precordial intrinsicoid deflection time in determining the conversion of Type 2 Brugada ECG pattern to Type 1 Brugada ECG pattern on 12-lead electrocardiogram with ajmaline test

Aim: Brugada syndrome is a genetic disorder associated with fatal ventricular arrhythmias. Type 1 (cove-type) ECG pattern is diagnostic for Brugada syndrome while Type 2 (saddle-type) ECG pattern requires ajmaline test to convert it to Type 1 ECG pattern to make the diagnosis. However, this test may cause ventricular arrhythmias and death. Intrinsicoid deflection time (IDT) is an ECG parameter reflecting intraventricular conduction delay, which is one of the pathophysiological mechanisms for Brugada syndrome. We examined IDT for conversion of type 2 Brugada pattern to type 1 Brugada pattern in ajmaline test.Materials and Methods: This retrospective study involved patients with Type 2 ECG pattern that was converted to Type 1 ECG pattern with ajmaline test (Group 1) and an age- and sex-matched control group with a normal ECG (Group 2). IDT was digitally measured in the lead V2, from the onset of the QRS complex to the peak of the R wave and compared between the study groups. A ROC curve was drawn to test the predictive ability of IDT for conversion to Type 1 ECG pattern. Results: There were 28 subjects (21 men, 7 women) in Group 1 and 28 subjects (21 men, 7 women) in Group 2. Group 1 had a significantly greater IDT than Group 2 (28 (17.1-78.0) msec vs 21 (16.0-36.9) msec; p

PDF

___

1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992;20:1391–96.
2. Antzelevitch C, Brugada P, Borggrefe M, et al. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005;111:659–70.
3. Nademanee K, Veerakul G, Nimmannit S, Chaowakul V, et al. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 1996;96:2595–600.
4. Tan HL, Hofman N, van Langen IM, et al. Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation 2005;112:207–13.
5. van der Werf C, Hofman N, Tan HL, et al. Diagnostic yield in sudden unexplained death and aborted cardiac arrest in the young: the experience of a tertiary referral center in The Netherlands. Heart Rhythm 2010;7:1383–9.
6. Mellor G, Raju H, de Noronha SV, et al. Clinical characteristics and circumstances of death in the sudden arrhythmic death syndrome. Circ Arrhythm Electrophysiol 2014;7:1078-83.
7. Garson A Jr, Dick M 2nd, Fournier A, et al. The long QT syndrome in children. An international study of 287 patients. Circulation 1993;87:1866–72.
8. Kapplinger JD, Tester DJ, Alders M, et al. An international compendium of mutations in the SCN5A encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm 2010:7:33–46.
9. Hu D, Barajas-Martínez H, Pfeiffer R, et al. Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome. J. Am. Coll. Cardiol 2014; 64:66–79.
10. Sarquella-Brugada G, Campuzano O, Arbelo E, et al. Brugada syndrome: clinical and genetic findings. Genet. Med 2016;18:3–12.
11. Coronel R, Casini S, Koopmann TT, et al. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study. Circulation 2005;112:2769–77.
12. Tauber PE, Mansilla V, Brugada P, et al. (June 20th 2018). Endocardial approach for substrate ablation in brugada syndrome, cardiac arrhythmias, umashankar lakshmanadoss, intechopen https://www.intechopen. com/books/cardiac-arrhythmias/endocardialapproach- for-substrate-ablation-in-brugadasyndrome.
13. Zhang P, Tung R, Zhang Z, et al. Characterization of the epicardial substrate for catheter ablation of Brugada syndrome. Heart Rhythm 2016;13:2151-8.
14. Guillem MS, Climent AM, Millet J, et al. Conduction abnormalities in the right ventricular outflow tract in Brugada syndrome detected body surface potential mapping. Conf Proc IEEE Eng Med Biol Soc 2010;2010:2537-40.
15. Nademanee K, Hocini M, Haïssaguerre M. Epicardial substrate ablation for Brugada syndrome. Heart Rhythm 2017;14:457-61.
16. Pérez-Riera AR, de Abreu LC, Barbosa-Barros R, et al. R-Peak time: an electrocardiographic parameter with multiple clinical applications. Ann Noninvasive Electrocardiol 2016;21:10-9.
17. Wilde AA, Antzelevitch C, Borggrefe M, et al; Study group on the molecular basis of arrhythmias of the european society of cardiology. proposed diagnostic criteria for the brugada syndrome. Eur Heart J. 2002;23:1648-54.
18. Rolf S, Bruns H, Wichter T, et al. The ajmaline challenge in Brugada syndrome: Diagnostic impact, safety, and recommended protocol. Eu Heart J 2003;24:1104-12.
19. O'Neal WT, Qureshi WT, Nazarian S, et al. Electrocardiographic time to intrinsicoid deflection and heart failure: the multi-ethnic study of atherosclerosis. Clin Cardiol 2016;39:531-6.
20. Darouian N, Narayanan K, Aro AL, et al. Delayed intrinsicoid deflection of the qrs complex is associated with sudden cardiac arrest. Heart Rhytm 2016;13:927- 32.
21. Del-Carpio Munoz F, Powell BD, Cha YM, et al. Delayed intrinsicoid deflection onset in surface ECG lateral leads predicts left ventricular reverse remodeling after cardiac resynchronization therapy. Heart Rhythm 2013;10:979-87.
22. Çiftçi O, Keskin S, Yılmaz KC, et al. The role of intrinsicoid deflection time in precordial leads facing right ventricle and avr for diagnosis of acute pulmonary thromboembolism and determination its severity. J Ankara Univ Fac Med 2018;71:135-40.
23. Tse G, Liu T, Li KH, et al. Electrophysiological mechanisms of brugada syndrome: insights from preclinical and clinical studies. Front Physiol 2016;7:467.
24. Szel T, Antzelevitch, C. Abnormal repolarization as the basis for late potentials and fractionated electrograms recorded from epicardium in experimental models of Brugada syndrome. J Am Coll Cardiol 2014;63:2037– 45.